Oncocytic tumors ofthe major salivaryglands are rare, accountingfor lessthan 1% ofall salivarygland tumors. When they do OCCUl; these neoplasms typically present as solitary nodules that affict only one major salivary gland, usually the parotid. Multiple bilateral multinodular tumors are rare. we report the case ofa 53-year-old woman with a case ofsyncbronousmultiple bilateral multinodular oncocytomas that arose in a background of bilateral oncocytic nodular hyper plasia in the parotid glands. The patient underwent superficial parotid resections, and at the 4-yearfollow-up, sheexhibited no evidence ofrecurrence.
Introd uction
Oncocytic salivary gland tumors are rare, accounti ng for fewer th an 1% of all salivary gland neoplasms.1. 2 
Althou gh
Mcfarland' is credited with describing th e first oncocytic salivary gland tumor in 1927, pion eering wor k by H amperl" publ ished in 1931 led the way to recognizing oncocytic cha nges, bo th hyperplastic and neopl astic. H amperl's subsequent report of 46 such lesion s, which was published in 1962, was th e first com prehensive review of oncocytic neo plasms. "
Oncocytomas usually present as solitary, and hence unilateral, lesion s. To date, only about 20 cases of bilateral tumors have been repo rted in th e world Iiterature.l'v' " T hese tumors presented as synchro nous o r metachronous lesion s of th e parot id glands to th e exclusion of th e other m ajor salivary glands.
In this article,we report a rare caseofsynchro no us mul tiple bilateral multinodular parot id oncocytomas th at arose in a backgrou nd of bilateral oncocytic nodular hyperplasia. We also discuss th e feature s th at characterize oncocyto mas and nodular hyperplasia based on our review of the existing limited literatu re on bilateral oncocyto m as.
Case report
A 53-year-old white woma n presented to our outpatient clinic with a 5-year history of a grad ual bilateral nodular enlargeme nt of her parot id glands. H er prim ary concern was th e d isfiguring effect of the nodulariry, particularly on th e left side of her face. She reported no pain , and she exhibited no signs of facial ne rve weakness. H er m edical , surg ical, fami ly, and social history was unremarkable, and all her laboratory tests, including a screen for human immunod eficiency virus, were negative. M agnetic reson ance imaging (M RI) of th e parotid areas had been obtained earlier by th e referring ph ysician . It showed multiple bilateral nonenhan cing parotid masses th at dem on strated variable intensity on T2 weighting (figure 1). Physical exam ination revealed th at th e nodules were firm and no nte nder, and they were indeed mo re prominent on the left. T he patient's neck was free of lymphadenopathy. Routine posteroanterior and lateral chest x-rays were norm al. Fine-needle aspiration was performed at multiple nodular sites;cytology consistently dem on strated a uni form oncocyric population of cells with no significant cyto logic atypia.This findi ng was consistent with a bilateral oncocytic lesion (differenti al d iagno sis: hyperplastic vs. neoplastic lesion) .T he patient underwent superficial parotid resection s, and th e parot id bed was recon structed with AlloDerm . The patient recovered from surgery without facial nerve weak ness or any ot her complication .
Gross exam ination ofthe resected parotid tissues revealed fragm ented nodular pieces of soft brown and tan tissue. Serial sectioni ng of the tissue fragm ents revealed d iscrete round nodules th at ranged in size from 0. what is typically seen in oncocytic morp hology, in which the nuclei are cent rally placed. The cells were arranged in solid, organoid, and trabecular patterns; thin fibrou s stroma and blood vessels separated the trabecular and organoid form s. Many of the nodule form ations blend ed imp ercept ibly with th e surro unding glandular tissue, with no apparent circumferential or intervening fibrous tissue formation; these formations had a more irregular outline (figure 4, C) . The larger, more dom inant nodul es were contai ned in well-defined, well-circu mscri bed fibrou s capsules that separated them from th e surro unding tissues (figure 4, D). No entrapped normal parotid gland eleme nts were observed. It is interesting that these encapsulated nod ules also exhibited more of a solid pattern of growth and occasional cyst formation. It th us becam e evident that there were two patterns of growth-hyperplastic and neoplastic. T he hyperplastic pattern was characterized by the unencapsulated nodu lar growth pattern and irregular outline. The neoplastic pattern was charac terized by the well-encapsulated, round, solid nod ules.
No evidence of malignant transform ation was evident . O n the basis of the cytologic features, we made a diagnosis of mu ltiple bilateral mu ltinod ular oncocytornas of the parotid glands arising in a background of mu ltifocal nod ular oncocytic hyperplasia.
T he patient was followed in our outpatient clinic, an d at 4 years postop eratively, she exhibited no evidence of recurrence.
Discussion
Cells with oncocytic mo rphology have been described in many organ systems throughout the body (e.g., kidney, thyroid, and breast) since th ey were first observed by Schaffer in 1897 in tissues from the upper aerodigestive tract. I I W ithin the salivary glands, the appea rance of these cells in focal metaplastic, hyperplastic, or neoplastic oncocytic processes is usually related to increasing age. They are seen most often in the sixth and sevent h decades ofl ife; rarely are they encounte red in patient s younger than 50 years. 4 ,12. 13 It is not ent irely clear whether the development of oncoeyrie neoplasia (benign oncocytoma/oncocytic carcinomas) is a discrete independent event or if it occurs along a continuum of oncocytic metaplasia/h yperplasia th at ultimately 52 · www.entjournal.com leads to a neoplastic cha nge. As is the case with many other well-researched pathologic events, it is reasonabl e to theor ize that both scenarios may be in play. Mo re research is certainly needed to clarify this point .
Etiologic factors th at may trigger neoplastic change includ e radiation exposure, metabolic mitochondrial defects, and genetic predisposition s. In this regard, Brandwein and Huvos' found a history of radiation exposure in some of their cases, and Becker et aP4 described an age-dependent intracellular metabo lic defect associated with mitochon- driopathy as an explana tion for th e d evelopment of oncocyt osis in 2 of their cases. However, th e pathogenesis of the proposed continuum (metaplasia/hyperpl asia/tumoral change) remains largely undefined. M ost investigators agree with th e World Health Organizati on's classification of oncocytic lesion s." The WHO groups th ese tumors into three distinct categori es: diffitseoncocytosis, multifocal nodularoncocytichyperplasia (MN0 H ), and oncocytomas (benign and mali gn ant).IS However, th e differentiati on between hyperpl asia and on cocytoma has been the subject of much debate. Som e investigators have discussed th e possibility th at a benign oncocytoma m ay not be a true neoplasm at all, but rather an encapsulated hyperplastic variant.8.1 6.l7 Others, including th e authors of this article, do not share th at view; we con sider oncocytomas and nodular hyperplasia to be two d istinct pathologic entities. Our position is supported by th e results ofa stu dy by Palm er er al, who reviewed 26 oncocytic salivary gland lesion s.13
They found th at th e m edian age for th e d evelopment of MNOH and on cocytoma tog ether (65yr) was higher th an th at for MNOH alon e (42 yr), This finding lends m ore support to the the ory of progressive tumoral cha nge in a hyp erpl astic process. Brandwein and Huvos described it best when th ey wrote th at th e development ofoncocytornas in a background of nodular oncocytic hyperplasia is analogous to th e d evelopment of a th yroid adenoma in a background of ade no ma to us th yroid goiter,'
Most autho rs d o agree th at th e m icros copic di fferentiati on between a h yp erplasti c oncoeyr ie n odule an d a tumoral nodule (benign oncocyto m a) is based primarily on th e presence or absence of a well-defined fibrous cap sule that enco mpasses th e tumor completely or at least partially and separates it from th e surrou ndi ng tissues. H yperpl astic nodules usua lly do not feature thi s enca psulatio n; th ey have an irregular outl ine th at blends into the circumferential tissues with no fibrous barri er, and th ey tend to be lobular rather than lobar.'>" Also, parotid oncocyrornas tend to be easily detectable clinically because th eir size typ ically ran ges from 1 to 7 em , which is larger than m ost of th e no d ules seen in MNOH . As a result, patients are m ore likely to seek m ed ical evaluation. world literatureand found that they occurred assynchronous or metachronous events." Some authors also reported the multinodular fashion by which some oncoeytomas present and warned against interpreting the rnultinodularity as a sign of malignancy." :'?
In the report by Brandwein and Huvos, who studied 68 oncocyt iclesions ofthe major salivary glands, the incidence of bilateraloncoeytomaswas 7%. 1These authors found that bilateral presentations correlated with significant clear-cell change. Ellis reviewed 10 cases of clear-cell oncoeytomas and found that clear-cell chan ge occurred secondary to glycogen accumulation; however, mitochondria were still the preponderant intracytoplasmic organelle, as they are in rypical oncocytornas."
Our patient, in her sixth decade of life, sought medic al attention after noticing the disfiguring facial effect caused by th e presence ofbilateral parotid region nodularity. Surgical excision followed by histologic evaluation revealed a difruse bilateral nodular oncoeytic hyperplasia of the parotid gland together with bilateral multinodular oncoeytomas tha t exhibited clear-cell features at focal areas. We have described this unusual case in an effort to stress to clinicians and pathologists alike the imp ortance of considering th is rare entity in the differential diagnosis of bilateral nodular parotid gland enlargement. This is particularly impo rtant when the treating physician and the pathologist are consideri ng a malignant process on the basis of the app earance of bilateral and multicentric tumor growth s.
